Type
. Analysis of a leprosy-specific antibody epitope. Leprosy review [Internet]. 1986;57 Suppl 2:157-62. Available from: http://leprev.ilsl.br/pdfs/1986/v57s2/pdf/v57s2a19.pdf
Type
. Immunologic aspects of leprosy. International journal of dermatology. 1986;25(7):452-5.
Type
. Effect of recombinant interferon-gamma on hydrogen peroxide-releasing capacity of monocyte-derived macrophages from patients with lepromatous leprosy. Journal of immunology (Baltimore, Md. : 1950). 1986;137(3):983-7.
Type
. Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy. The New England journal of medicine. 1986;315(1):6-15.
Type
. [Treatment of leprosy by human metabolites]. Acta leprologica. 1986;4(3):363-72.
Type
. The nationalization of a disease: a paradigm?. Public health reports (Washington, D.C. : 1974) [Internet]. 1986;101(4):399-404. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1477738/pdf/pubhealthrep00182-0061.pdf
Type
. Detection of mycobacterial antigens in leprosy serum immune complex. Journal of clinical microbiology [Internet]. 1986;24(1):169-71. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC268861/pdf/jcm00097-0187.pdf
Type
. In vitro studies on dermal granulomas of human leprosy: characterization of cells using monoclonal antibodies. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1986;54(2):268-72.
Type
. Influence of delayed immune reactions on human epidermal keratinocytes. Proceedings of the National Academy of Sciences of the United States of America. 1986;83(10):3469-73.
Type
. The clinical significance of erythema nodosum. Hospital practice (Office ed.). 1986;21(3):102E-102H, 102K-102L, 102Q-102R pas.